NEW YORK, July 24 - Cepheid announced on Tuesday second-quarter revenues of $2 million, compared to $1.2 million from the year ago period. For the six months ended June 30, Cepheid's revenues increased to $5.4 million from $2.1 million.

The maker of equipment for rapidly preparing and analyzing DNA attributed the increase to the extension of sales of its Smart Cycler DNA testing system. During this latest quarter, Cepheid sold the Smart Cycler within North America, Europe, and Asia; in the year ago period, it had access to only the US market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.